Fisher & Paykel Healthcare beats earnings guidance revenue as ‘triple-demic’ looms the in US

Fisher & Paykel Healthcare beats earnings guidance revenue as ‘triple-demic’ looms the in US
Health experts are concerned by the simultaneous spread of three respiratory illnesses in the United States. (Photo: Getty)
Dan Brunskill
Fisher & Paykel Healthcare has reported half-year earnings ahead of analyst expectations and their own market guidance, with operating revenue at $690.6 million.The company had told the market to expect revenue to be $670m in its August trading update, warning that many customers were already stocked up on hospital products.Even though the higher-than-expected revenue was 23% lower than in the first half of the prior year, it was a 21% increase on the pre-pandemic period first half of 2020.Fisher & Paykel Healthcare's (FPH) chief ex...

More Markets

NZ sharemarket lifts into positive territory for the year
Markets Market close

NZ sharemarket lifts into positive territory for the year

The S&P/NZX 50 Index closed at 11,496.61, up 33.12 points or 0.29%.

Air NZ’s 'small but mighty' step towards green aviation
Markets

Air NZ’s 'small but mighty' step towards green aviation

The carrier has bought an all-electric aircraft from Beta Tech, to be delivered in 2026.

Xero, Tourism Holdings, NZME among Deloitte Top 200 winners
Markets

Xero, Tourism Holdings, NZME among Deloitte Top 200 winners

The prestigious Deloitte Top 200 Awards winners were revealed on Wednesday evening.

ComCom: Is it time to deregulate fibre broadband?
Markets

ComCom: Is it time to deregulate fibre broadband?

The review is the first under a new regulatory regime.